Terran Orbital (NYSE:LLAP) Gets Boost from Contract News Amid Market Challenges
by Marlena Haddad on 2023-10-26 at 2:27pm

Much like its peers in the world of space de-SPACs, Tailwind Two‘s de-SPAC Terran Orbital (NYSE:LLAP) has weathered its fair share of market turbulence, including a NYSE delisting notice for trading under a $1. But, the company could be headed for a comeback, zooming up +26.5% over the past week on positive headlines.

The satellite manufacturer made waves in the space industry yesterday by announcing a new contract with the European Space Agency. Valued at $4.7 million, the contract revolves around an ambitious in-orbit servicing mission, involving the deployment of a nanosatellite spacecraft from Space Rider, the agency’s uncrewed robotic laboratory.

Terran Orbital’s ascent continued this morning as defense contractor Lockheed Martin (NYSE:LME) awarded a further $7.7 million contract to the company. This contract is part of an ongoing satellite design and manufacturing program, with the cumulative value of the contract reaching up to $52 million.

Terran Orbital already has a well-established partnership with Lockheed Martin, which invested in its $50.8 million PIPE connected to the Tailwind Two deal. So, more projects between the duo could be on the horizon.

Last year, Terran Orbital delivered 10 satellite buses to Lockheed in support of its Tranche 0 Transport Layer contract and it is already working on 42 more for Tranche 1 scheduled to launch in 2024. The company was recently awarded the contract for 36 more buses for Tranche 2, for a total $816 million contract, slated for completion in late 2026.

These developments could swing some momentum for Terran Orbital, or at least get it over the $1 requirement for the NYSE. The company opened today at $0.87 having entered the week at $0.65, and it is down slightly in mid-afternoon trading to about $0.82.

If this news does not do the trick, Terran Orbital is exploring various avenues to regain compliance, among them a reverse stock split, contingent upon stockholder approval.

The company’s CEO, Mark Bell, is set to address this price deficiency issue at a meeting today to give shareholders more transparency around this and its contracts in an attempt to improve its standing in the market.

Terran Orbital stands among a group of 13 other space de-SPACs, which last closed at a median price of $1.76. Many of these peers have already turned to stock splits to propel them over the $1 threshold. Adjusted for such splits, this group trades at a median price of $1.07.

 

Terran Orbital (NYSE:LLAP) Gets Boost from Contract News Amid Market Challenges
Recent Posts
by Nicholas Alan Clayton on 2025-06-26 at 7:04pm

FIGX Acquisition Corp. (NASDAQ:FIGXU) announced the pricing of its $131 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FIGXU”, Friday, June 27, 2025. The new SPAC aims to seek out a financial services target with a particular focus on wealth and asset managers with the potential to...

by Nicholas Alan Clayton on 2025-06-26 at 4:52pm

Yorkville Acquisition Corp. (NASDAQ:YORKU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “YORKU”, Friday, June 27, 2025. The new SPAC plans to combine with a target company in the telecom, media or technology sectors. Yorkville Acquisition Corp.’s management team is led...

by Nicholas Alan Clayton on 2025-06-26 at 8:24am

At the SPAC of Dawn As pressure on Fed Chairman Jerome Powell increases, the market is set to ingest a raft of new indicators today as well as hear from Cleveland Fed President Beth Hammack on the potential interest rate path. Today will also see June’s 8th SPAC IPO as Cantor Equity Partners III Inc....

by Nicholas Alan Clayton on 2025-06-25 at 6:30pm

Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 26, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...

by Nicholas Alan Clayton on 2025-06-25 at 12:44pm

Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved